Robins Kaplan, Two Partners Shortlisted for LMG Life Sciences Awards
July 26, 2023
Robins Kaplan LLP is pleased to announce that Jake Holdreith and Oren Langer have been selected as finalists in LMG Life Sciences 2023 Americas Awards. Holdreith was named to the shortlist for General Patent Litigator of the Year – Midwest, while Langer was selected to the Hatch-Waxman Litigator of the Year – Generic shortlist. Additionally, the firm was shortlisted for Hatch-Waxman Litigation Firm of the Year – Generic.
Holdreith is a member of the firm’s executive board and the leader of the firm’s life sciences group. A skilled and creative strategist, he has tried jury cases to multi-million-dollar verdicts and resolved complex cases at all stages of litigation. Holdreith is known for his work in the pharmaceutical, chemical, and electronics industries and has handled cases in the United States, Europe, and Asia. Last year, Holdreith was named “Hatch-Waxman Litigator of the Year – Generic” and received the “Patent Impact Case of the Year” award from LMG Life Sciences. He has also been regularly recognized as a “Life Sciences Star.”
Langer serves as Managing Partner of the firm’s New York office. An accomplished patent litigator, he has worked extensively under the Hatch-Waxman regulatory framework. He’s examined and cross-examined fact and expert witnesses at nearly one dozen trials, representing a variety of clients, including Collegium Pharmaceutical, Inc., Amneal Pharmaceuticals, Inc., Hikma Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Ltd., and Novel Labs. In 2022, among other accolades, Langer was named a recommended litigator in the IAM Patent 1000 and a “Life Sciences Star” by LMG Life Sciences.
You can find a complete list of the nominees here. The winners of this year’s awards will be announced at a ceremony in New York City on September 7, 2023.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.